StephenJ.MeltzerMD
Gastroenterology • Lutherville, MDProfessor of Medicine, Professor of Oncology, Johns Hopkins University School of Medicine
Dr. Meltzer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2360 W. Joppa Road
Joppa Concourse Suite 205
Lutherville, MD 21093Phone+1 410-933-7495- Is this information wrong?
Education & Training
Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalFellowship, Gastroenterology, 1984 - 1985
University of ColoradoFellowship, Gastroenterology, 1983 - 1984
University of Texas Medical Branch HospitalsResidency, Internal Medicine, 1980 - 1982
Tulane UniversityInternship, Internal Medicine, 1979 - 1980
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1979
Certifications & Licensure
CA State Medical License 1985 - Present
MD State Medical License 1988 - 2025
CO State Medical License 1982 - 1985
TX State Medical License 1980 - 1983
LA State Medical License 1979 - 1983- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Elected Member The American Society for Clinical Investigation, 1997
Clinical Trials
- EsophaCap for the Detection of Early Esophageal Carcinoma Start of enrollment: 2016 Jan 12
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Establishing mouse and human oral esophageal organoids to investigate the tumor immune response.Jiang, Y., Zhao, H., Kong, S., Zhou, D., Dong, J., Cheng, Y., Zhang, S., Wang, F., Kalra, A., Yang, N., Wei, D., Chen, J., Zhang, Y., Lin, D., Jiang, Y., Meltzer, S.> ;Disease Models & Mechanisms. 2024 Jan 1
- 12 citationsGeneration and multiomic profiling of adouble-knockout gastroesophageal junction organoid model.Hua Zhao, Yulan Cheng, Andrew Kalra, Ke Ma, Yueyuan Zheng, Benjamin Ziman, Caitlin Tressler, Kristine Glunde, Eun Ji Shin, Saowanee Ngamruengphong, Mouen Khashab, Vike...> ;Science Translational Medicine. 2022 Nov 30
- 11 citationsVimentin binds to a novel tumor suppressor protein, GSPT1-238aa, encoded by circGSPT1 with a selective encoding priority to halt autophagy in gastric carcinoma.Fan Hu, Yin Peng, Shanshan Chang, Xiaonuan Luo, Yuan Yuan, Xiaohui Zhu, Yidan Xu, Kaining Du, Yang Chen, Shiqi Deng, Fan Yu, Xianling Feng, Xinmin Fan, Hassan Ashktora...> ;Cancer Letters. 2022 Oct 1
- Join now to see all
Journal Articles
- Inhibition of the miR-192/215–Rab11-FIP2 Axis Suppresses Human Gastric Cancer ProgressionStephen Meltzer, MD, Nature
Press Mentions
Previse Closes $3m Seed to Tackle Early Cancer Detection and Launches Company's First Esophageal Cancer Prognostic TestMarch 21st, 2023- Maryland’s Only Hospital-Based Bioincubator Making InroadsMay 25th, 2022
- Preliminary Study Shows Minimally Invasive Diagnostic Biomarker Strategy Successful in Detecting Esophageal CancerMay 18th, 2022
- Join now to see all
Grant Support
- The Temporal Epigenomic Program Of Barrett'S Neoplastic ProgressionNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- The Role Of Microrna Alterations In Barrett'S CarcinogenesisNational Cancer Institute2009–2011
- Inflammatory Bowel Disease-Associated Malignant TransformationNational Cancer Institute2009–2011
- Comprehensive Biomarker Development In Early EsophagogasNational Cancer Institute2006–2009
- The Human Colorectal InstabilitomeNational Cancer Institute2006–2007
- Neoplastic Complications In Inflammatory Bowel DiseaseNational Cancer Institute2006–2007
- Genomics: Esophageal Metaplasia-Associated MalignancyNational Cancer Institute2006
- Neoplastic Complications In Inflammatory Bowel DiseaseNational Cancer Institute2003–2006
- Research Training In GastroenterologyNational Institute Of Diabetes And Digestive And Kidney Diseases2005
- Validation Studies Of Circulating Methylation BiomarkersNational Cancer Institute2005
- Comprehensive Biomarker Development In Early EsophagogasNational Cancer Institute2004–2005
- The Human Colorectal InstabilitomeNational Cancer Institute2003–2005
- Novel Methylation Targets In Gastric CancerNational Cancer Institute2003–2005
- Genomics: Esophageal Metaplasia-Associated MalignancyNational Cancer Institute2002–2005
- Comprehensive Biomaker Development In Early EsophagogastNational Cancer Institute1999–2003
- Human Colorectal InstabilitomeNational Cancer Institute1998–2002
- Neoplastic Complications In Inflammatory Bowel DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1993–2001
- Igfir In Human GI TumorsNational Cancer Institute1998–2000
- Nitric Oxide In Helicobacter-Associated Gastric CancerNational Cancer Institute1995–1997
Other Languages
- French, German
Hospital Affiliations
Johns Hopkins HospitalBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/stephen-meltzer
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
